World's Best Scientists 2026 revealed!
Cancer Treatment and Research
H-index 16

Cancer Treatment and Research

0927-3042

Published by: Springer

https://www.springer.com/series/5808

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1523 102 90 16

Additional Metrics

Number of Best Scientists*: 140
Documents by Best Scientists*: 117
Top 100 Ranked Scientists*: 2
SCIMAGO H-index: 68
SCIMAGO SJR: 0.133
Impact Factor: N/A

Overview

Top Research Topics at Cancer treatment and research?

The main research concerns discussed in Cancer treatment and research are Internal medicine, Oncology, Cancer, Cancer research and Disease. Cancer treatment and research explores research in Internal medicine and the adjacent study of Gastroenterology. The Oncology works featured in it incorporate elements from Stage (cooking), Lymphoma, Prostate cancer and Immunotherapy.

The work on Cancer tackled in Cancer treatment and research brings together disciplines like Malignancy, Pathology and Intensive care medicine. Some problems in Cancer research that were presented in the journal overlapped with concepts under Carcinogenesis, Gene, Cancer cell and Metastasis. Most of the Disease studies addressed also intersect with Immunology.

Research in the field of Surgery was used to conduct the presented Chemotherapy study. It explores the study of Radiation therapy to improve our understanding of the broader topic of Radiology.

  • Internal medicine (31.92%)
  • Oncology (25.28%)
  • Cancer (23.64%)

What are the most cited papers published in the journal?

  • The Epidemiology of Osteosarcoma (1016 citations)
  • Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis (947 citations)
  • Quality-of-life assessment in clinical trials (333 citations)

Research areas of the most cited articles at Cancer treatment and research:

The journal papers generally zeroe in on subjects such as Cancer research, Cancer, Internal medicine, Oncology and Pathology. The journal articles facilitate discussions on Cancer research that incorporate concepts from other fields like Carcinogenesis, Cancer cell and Metastasis. The most cited articles deal with Cancer in conjunction with Immunology and similar fields in Epidemiology.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Disease

The previous edition focused in particular on these issues:

Cancer treatment and research investigates studies in Internal medicine, Oncology, Cancer, Cancer research and Lung cancer. The study on Internal medicine presented in it intersects with subjects under the field of Gastroenterology. Cancer treatment and research holds forums on Oncology that merges themes from other disciplines such as Adverse effect, Targeted therapy, Breast cancer, Prostate cancer and Immunotherapy.

In Cancer treatment and research, Malignancy, Retrospective cohort study, Intensive care medicine, Coronavirus disease 2019 (COVID-19) and Radiation therapy are investigated in conjunction with one another to address concerns in Cancer research. Cancer treatment and research facilitates discussions on Cancer research that incorporate concepts from other fields like Cancer cell, Apoptosis, T cell and Carcinogenesis, Gene. The journal investigates Lung cancer research which frequently intersects with Adenocarcinoma.

The most cited articles from the last journal are:

  • First-line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC-02 Trial: "And Yet It Moves!" (8 citations)
  • Pemigatinib: Hot topics behind the first approval of a targeted therapy in cholangiocarcinoma (7 citations)
  • Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Cancer treatment and research (based on the number of publications) are:

  • Paul H. Sugarbaker (27 papers) absent at the last edition,
  • Teresa K. Woodruff (11 papers) absent at the last edition,
  • Norman Jaffe (10 papers) absent at the last edition,
  • Richard E. Champlin (9 papers) absent at the last edition,
  • Alessandro Rizzo (8 papers) published 8 papers at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Cancer treatment and research (based on the number of publications) are:

  • Northwestern University (161 papers) published 1 paper at the last edition,
  • University of Texas MD Anderson Cancer Center (115 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • City of Hope National Medical Center (54 papers) published 14 papers at the last edition, 9 more than at the previous edition,
  • Harvard University (54 papers) absent at the last edition,
  • Memorial Sloan Kettering Cancer Center (50 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 12.20% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 10.65% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.48% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 10.19% of all publications and 72.69% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Qualifications and Career Paths for Oncology and Internal Medicine Practitioners

One potential area of interest to readers could be exploring the qualifications required to pursue a career in oncology and internal medicine, two key fields deeply interconnected in cancer treatment and research. To become an oncologist, one must obtain a medical degree (MD), complete a residency program in Internal Medicine, and then specialize in Oncology through fellowship training. The oncologist is expected to stay up to date with advancements made in the field, as cancer research is crucial to provide effective treatments and patient care. Internal medicine practitioners encompass a broad range of specialties. Among them, some choose to sub-specialize in Oncology, fulfilling a vital role in effectively diagnosing and treating cancer patients. They must also stay conversant with recent breakthroughs in cancer research, given its dynamic nature. While the paths to becoming an expert in Oncology or Internal Medicine may be arduous, they are also rewarding and fascinating, offering continuous learning opportunities and the chance to make significant contributions towards medical advancements. Many potential career paths and specializations are available depending on one's interests and skills, from research to patient care to education. Those interested in pursuing such a path in the state of Georgia may wish to explore the best np programs in Georgia to get started on a rewarding path towards specialized patient care. This information is vital for prospective students, researchers, or medical practitioners considering a career in oncology or internal medicine fields.

Top Publications

  • Utilization of systemic therapy for treatment of advanced urothelial carcinoma: Lessons from real world experience

    Umang Swami;Petros Grivas;Sumanta K. Pal;Neeraj Agarwal

    (2021)
    44 Citations
  • Recent advancements in the treatment of metastatic clear cell renal cell carcinoma: A review of the evidence using second-generation p-values.

    Jacob J. Adashek;Giannicola Genovese;Nizar M. Tannir;Pavlos Msaouel

    (2020)
    31 Citations
  • The significance of sarcomatoid and rhabdoid dedifferentiation in renal cell carcinoma.

    (2022)
    29 Citations
  • Clinico-pathological predictors of clinical complete response in rectal cancer.

    (2022)
    28 Citations
  • Hyperthermic intraperitoneal chemotherapy (HIPEC) after primary debulking surgery in advanced epithelial ovarian cancer: Is BRCA mutational status making the difference?

    (2022)
    28 Citations
  • Emerging treatments for metastatic castration-resistant prostate cancer: Immunotherapy, PARP inhibitors, and PSMA-targeted approaches

    Catherine Handy Marshall;Emmanuel S. Antonarakis

    (2020)
    27 Citations
  • Impact of the COVID-19 outbreak on prostate cancer care in the Netherlands

    (2022)
    27 Citations
  • Utilization of systemic treatment for metastatic bladder cancer in everyday practice: Results of a nation-wide population-based cohort study

    Anke Richters;Niven Mehra;Richard P. Meijer;Joost L. Boormans

    (2020)
    25 Citations
  • Predictive factors associated with radiation dermatitis in breast cancer.

    Tara Behroozian;Lauren Milton;Nim Li;Liying Zhang

    (2021)
    24 Citations
  • Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study.

    Sebastiano Buti;Melissa Bersanelli;Alessandro Viansone;Alessandro Leonetti

    (2020)
    23 Citations

Related Online Degrees & Career Pathways

For those interested in pursuing a career in healthcare but looking for alternative entry points, several online degree options provide flexible pathways. For example, a ma to lpn bridge program online allows existing medical assistants to advance their qualifications and become licensed practical nurses without attending traditional on-campus classes.

Biology remains a foundational science for many medical careers, and an online degree can offer the same rigorous education with greater accessibility. Check out programs offering a biology degree online, which often include accelerated options to help students complete their studies in less time.

Nursing is another promising field within medicine, with numerous online paths available. Aspiring nurses can enroll in an asn program online to earn an associate’s degree and enter the workforce quickly, often with the option to continue their education later.

Nutrition science is increasingly recognized for its role in healthcare and disease prevention. Those interested can pursue an online nutrition degree to open career opportunities in dietetics, wellness coaching, and public health.

Best Scientists Contributing to This Journal